JIPOAd
ESID
TCR
  • Users Online: 167
  • Print this page
  • Email this page

  Reader Comments

Year : 2019 | Volume:  2 | Issue Number:  3

EDITORIAL

Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy

Hajjar Joud

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article
CALL FOR PAPERS
Special issue 2019